The investment is split across three sites and details of the work up for grabs are:
- Barnard Castle in County Durham will receive £92m to fund the construction of an aseptic sterile facility.
- Montrose in Angus in Scotland will get £110 million for a new, state-of-the-art facility for the manufacture of respiratory active ingredients.
- Ware in Hertfordshire will receive £74 million for additional manufacturing capacity at the site.
Andrew Witty, CEO, GSK said, ‘Today’s announcement reflects further investment to support our pharmaceutical pipeline and meet growing demand for our innovative portfolio of newly launched products.
“It is testament to our skilled UK workforce and the country’s leading position in life sciences that we are making these investments in advanced manufacturing here.
“From their manufacture in the UK, many of these medicines will be sent to patients around the world.”